author-photo

Tim Wyant

Takeda Pharmaceutical Company

48

Papers

3095

Citations

Citation Trend

Filter By

Papers (34) Sort By

Journal Conference Others

Tu1742 – Long-Term Immunogenicity of Intravenous Vedolizumab in Ulcerative Colitis and Crohn's Disease (Gemini Program)

2019 Gastroenterology
Show All
- Source
- Cite
- Save
Citations (0)
Fecal Calprotectin Responses Following Induction Therapy With Vedolizumab in Moderate to Severe Ulcerative Colitis: A Post Hoc Analysis of GEMINI 1

2019 Inflammatory Bowel Diseases
Show All
- Source
- Cite
- Save
Citations (18)
A monomethyl auristatin E-conjugated antibody to guanylyl cyclase C is cytotoxic to target-expressing cells in vitro and in vivo

2018 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (12)
A Review of the Clinical Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Vedolizumab

2017 Clinical Pharmacokinectics
Show All
- Source
- Cite
- Save
Citations (80)
512 Association of Vedolizumab Drug Concentrations at or Before Week 6 With Remission at Week 14 in Moderately to Severely Active Ulcerative Colitis Patients From GEMINI 1

2016 Gastroenterology
Show All
- Source
- Cite
- Save
Citations (7)
Plasma exposure to metabolites of monomethyl auristatin E (MMAE) in patients with relapsed/refractory Hodgkin lymphoma (HL) treated with brentuximab vedotin (BV)

2016 Clinical Pharmacology & Therapeutics
Show All
- Source
- Cite
- Save
Citations (0)
Phase I Study of the Investigational Anti-Guanylyl Cyclase Antibody-Drug Conjugate TAK-264 (MLN0264) in Adult Patients with Advanced Gastrointestinal Malignancies.

2016 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (25)
An Overview of the Mechanism of Action of the Monoclonal Antibody Vedolizumab

2016 Journal of Crohns & Colitis
Show All
- Source
- Cite
- Save
Citations (95)
Vedolizumab affects antibody responses to immunisation selectively in the gastrointestinal tract: randomised controlled trial results.

2015 Gut
Show All
- Source
- Cite
- Save
Citations (110)
Enhancing enrollment using cohort surveillance for phase II biomarkers driven studies in patients with gastric/GEJ and pancreatic cancer.

2015 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)